Full Name
Alan Prem Kumar
Variants
Kumar, A.P.
Kumar, A.
Prem Kumar, A.
Kumar, Alan Prem Rem
 
 
 
Email
apkumar@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Department:  DEAN'S OFFICE (MEDICINE)
Subject:  Apoptosis
Date Issued:  [2010 TO 2019]

Results 1-17 of 17 (Search time: 0.011 seconds).

Issue DateTitleAuthor(s)
12013An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteinsSubramaniam, A.; Loo, S.Y.; Rajendran, P.; Manu, K.A. ; Perumal, E.; Li, F.; Shanmugam, M.K. ; Siveen, K.S.; Park, J.-I.; Ahn, K.S.; Hui, K.M.; Kumar, A.P. ; Sethi, G.
21-Sep-2011Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathwayWoo, C.C.; Loo, S.Y.; Gee, V.; Yap, C.W. ; Sethi, G.; Kumar, A.P. ; Benny Tan, K.H.
3Oct-2011Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathwaysKannaiyan, R.; Manu, K.A. ; Chen, L.; Li, F.; Rajendran, P.; Subramaniam, A.; Lam, P.; Kumar, A.P. ; Sethi, G.
4Apr-2013Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: Evidence for non-canonical activation of RhoA and Rac1 GTPasesZhu, Y.; Casey, P.J. ; Kumar, A.P. ; Pervaiz, S.
52015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
62019Inhibition of TFF3 enhances sensitivity—and overcomes acquired resistance—to doxorubicin in estrogen receptor-positive mammary carcinomaPoh, H.M.; Chiou, Y.S.; Chong, Q.Y. ; Chen, R.-M. ; Rangappa, K.S.; Ma, L.; Zhu, T.; Kumar, A.P. ; Pandey, V.; Basappa, Department of Studies in Organic Chemistry, University of Mysore, Mysore, 570005, India.; Lee, S.-C. ; Lobie, P.E. 
715-Nov-2012Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancerPrasannan, R.; Kalesh, K.A.; Shanmugam, M.K. ; Nachiyappan, A.; Ramachandran, L.; Nguyen, A.H.; Kumar, A.P. ; Lakshmanan, M.; Ahn, K.S.; Sethi, G.
8Jan-2013Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinomaSubramaniam, A.; Shanmugam, M.K. ; Perumal, E.; Li, F.; Nachiyappan, A.; Dai, X.; Swamy, S.N.; Ahn, K.S.; Kumar, A.P. ; Tan, B.K.H.; Hui, K.M.; Sethi, G.
92018Pro-apoptotic and anti-cancer properties of diosgenin: A comprehensive and critical reviewSethi, G ; Shanmugam, M.K ; Warrier, S; Merarchi, M; Arfuso, F; Kumar, A.P ; Bishayee, A
102013Role of NF-κB in tumorigenesisShanmugam, M.K. ; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
112014Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene productsManu, K.A.; Shanmugam, M.K. ; Li, F.; Chen, L.; Siveen, K.S.; Ahn, K.S.; Kumar, A.P. ; Sethi, G.
121-Dec-2013Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancerShrimali, D.; Shanmugam, M.K. ; Kumar, A.P. ; Zhang, J.; Tan, B.K.H.; Ahn, K.S.; Sethi, G.
1328-Jul-2012Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: Potential role in prevention and therapy of cancerShanmugam, M.K. ; Nguyen, A.H.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.
142014Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse modelSiveen, K.S ; Mustafa, N ; Li, F ; Kannaiyan, R; Ahn, K.S; Kumar, A.P ; Chng, W.-J ; Sethi, G 
1515-Feb-2012Thymoquinone: Potential cure for inflammatory disorders and cancerWoo, C.C.; Kumar, A.P. ; Sethi, G.; Tan, K.H.B.
162014?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen K.S. ; Ahn K.S.; Ong T.H.; Shanmugam M.K. ; Li F. ; Yap W.N.; Kumar A.P. ; Fong C.W.; Tergaonkar V. ; Hui K.M. ; Sethi G. 
171-Jun-2013Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studiesShanmugam, M.K. ; Dai, X.; Kumar, A.P. ; Tan, B.K.H.; Sethi, G.; Bishayee, A.